EIR Altaire Pharmaceuticals Mar 2012

Robert Horan FDA$595.00 - Available Now

FDA investigators audited the Altaire Pharmaceuticals - Aquebogue, NY, United States facility and issued inspectional observation (via FDA 483) on 19 Mar 2012.

Product details

  • Category:
  • Inspection end: 19 Mar 2012
  • Location: Aquebogue, United States
  • FEI: 1000119582
Add To Cart